New Strong Sell Stocks for September 19th

Zacks has designated Assertio (ASRT), Celanese (CE), and ARMOUR Residential REIT (ARR) as "Strong Sell" stocks, citing significant downward revisions to their current year earnings consensus estimates. Assertio's estimate was revised down by 63%, Celanese's by 14.2%, and ARMOUR Residential REIT's by 7.1% over the last 60 days, signaling a deteriorating financial outlook for these companies.

Analysis

Zacks has issued a "Strong Sell" (Rank #5) rating for three distinct companies—Assertio (ASRT), Celanese (CE), and ARMOUR Residential REIT (ARR)—based on significant recent downward revisions to their current year earnings consensus estimates. The magnitude of these revisions is a critical negative signal, with Assertio, a specialty pharmaceutical firm, experiencing the most severe cut of nearly 63% over the last 60 days. Celanese, a global chemical company, saw a substantial 14.2% downward revision, while ARMOUR Residential REIT, an investor in mortgage-backed securities, had its estimate reduced by 7.1%. These quantifiable deteriorations in analyst expectations point to a weakening fundamental outlook for each company, suggesting potential underlying operational challenges or adverse sector-specific headwinds that have materialized over the past two months.

Key Decisions for Investors

• Investors with long positions in ASRT, CE, or ARR should treat these "Strong Sell" ratings and the associated earnings estimate cuts as a material negative catalyst, warranting an immediate review of their investment thesis.
• Given the exceptionally sharp 63% downward earnings revision for Assertio (ASRT), initiating or adding to a long position carries significant risk until the drivers of this collapse in profitability expectations are fully understood.
• For Celanese (CE) and ARMOUR Residential REIT (ARR), the substantial estimate reductions signal weakening fundamentals, suggesting a defensive posture such as reducing exposure or implementing hedging strategies may be prudent to mitigate downside risk.
• The strong bearish sentiment, particularly for ASRT, may present a compelling case for short-biased investors or those seeking to hedge exposure in the specialty pharma, chemicals, or mortgage REIT sectors.